Ryan Haumschild, PharmD, MS, MBA, leads a discussion around the epidemiology of multiple sclerosis. Today, our panel of experts will explore the treatment landscape and impact of multiple sclerosis ...

Peter L. Salgo, MD: Before we use a very broad brush, which we’ve been doing, to discuss multiple sclerosis [MS], we’ve been able to get the subgroups and subtypes, right? There are different kinds of ...

Multiple sclerosis is a disease that may affect any area of the nervous system, thus causing a wide variety of symptoms such as visual problems, weakness, or numbness. Although the exact cause is ...

Use of medical informatics for management of multiple sclerosis using a chronic-care model, pg. 1 The authors describe how the Multiple Sclerosis (MS) Centers of Excellence use healthcare information ...

Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients. The ...

Multiple sclerosis (MS) is characterized by a broad array of symptoms. Despite this variability, most individuals with MS will exhibit a distinct set of symptoms during their initial clinical attack.

DelveInsight's“ Multiple Sclerosis Pipeline Insight 2026” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in the Multiple Sclerosis pipeline landscape. It covers the ...

Selma Blair revealed she was diagnosed with multiple sclerosis (MS), a central nervous system disease, in August 2018 and has been open about her experience with the condition. Blair has experienced ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Multiple Sclerosis Market and Competitive Landscape Highlights - 2016" report to their offering. The latest ...

DUBLIN--(BUSINESS WIRE)--The "Europe Multiple Sclerosis Market and Competitive Landscape - 2018" report has been added to ResearchAndMarkets.com's offering. Europe Multiple Sclerosis Market and ...